Cempra Pharmaceuticals

Research, PHARMA TECH

Ionis Pharmaceuticals, Inc. | March 10, 2023

Ionis Pharmaceuticals, a leading RNA-targeted therapy firm, recently announced that the USFDA has accepted for review a new drug application (NDA) for eplontersen. Eplontersen is an investigational antisense medicine designed to reduce the production of transthyretin (TTR) protein and treat hereditary and non-hereditary forms of ATTR amyloidosis (ATTR). The NDA has been given a Prescription Drug User Fee Act (PDUFA) action date of December 22, 2023. The FDA has declared that no ...

Pharma Tech

Pfizer | January 11, 2021

Newly emerged variants of the novel coronavirus have sparked a key question: Will existing COVID-19 vaccines be less effective against them? But scientists have preliminary data showing that may not be the case, at least for Pfizer and BioNTech’s shot. Researchers from the University of Texas and Pfizer found that, in lab dishes, the vaccine was able to neutralize an engineered version of a variant, which bears an N501Y mutation in its spike protein. The finding was publishe...

Pharmacy Market

Globenewswire | August 14, 2023

Tonix Pharmaceuticals Holding Corp. a biopharmaceutical company, today announced the completion of the clinical phase of the Phase 2 proof-of-concept PREVAIL study of TNX-102 SL as a potential treatment for fibromyalgia-type Long COVID. Topline results for the PREVAIL study are expected in the third quarter of 2023. “Approximately 40% of U.S. Long COVID patients have fibromyalgia-like multi-site pain symptoms based on our observational studies of Long COVID patients from t...

Business Insights

Satio, Inc and Institut Pasteur de Dakar | August 24, 2022

Satio, Inc., a privately held medical device company developing breakthrough, consumer-driven diagnostic and drug delivery solutions, announced a strategic partnership agreement with Institut Pasteur de Dakar. By combining SatioRxTM intradermal patches and Institut Pasteur de Dakar technologies, the partnership aims to accelerate clinical development of and access to vaccine patches for addressing epidemics, as well as diagnostic patches for blood sampling, genetic testing, and pa...